Skip to main content

Want a detailed portfolio tracker?

Korro Bio (KRRO) P/E (2023 - 2026)

Korro Bio (KRRO) P/E from Nov 6, 2023 to Jul 21, 2026. The TTM Korro Bio (KRRO) P/E is -8.79. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Korro Bio (KRRO)

YearP/EChange
2026-8.79+483.22%
2025-1.51-91.05%
2024-16.84-91.59%
2023-200.32N/A

Comparison Korro Bio (KRRO) P/E with competitors

Korro Bio (KRRO) P/E is -8.79.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.85%
FGENFibroGen Inc0.24-102.73%
CHRSCoherus Biosciences Inc0.85-109.65%
FBIOFortress Biotech Inc0.95-110.79%
ORMPOramed Pharmaceuticals Inc1.50-117.10%
AGENAgenus Inc3.01-134.23%
INVAInnoviva Inc3.15-135.87%
VXRTVaxart Inc3.55-140.37%
CRMDCorMedix Inc3.63-141.27%
CVACCureVac N.V.4.45-150.56%
GLPGGalapagos NV4.86-155.26%
SRPTSarepta Therapeutics Inc4.88-155.53%
ABEOAbeona Therapeutics Inc5.39-161.28%
ABUSArbutus Biopharma Corp5.60-163.64%
ZVRAZevra Therapeutics Inc5.89-166.96%
SPROSpero Therapeutics Inc6.23-170.84%
CGENCompugen Ltd6.31-171.81%
RIGLRigel Pharmaceuticals6.87-178.16%
SLXNSilexion Therapeutics Corp7.30-182.98%
OMEROmeros Corporation9.26-205.31%
AUPHAurinia Pharmaceuticals Inc9.58-209.02%
PLXProtalix BioTherapeutics Inc10.89-223.87%
ACADAcadia Pharmaceuticals Inc11.73-233.40%
TBPHTheravance Biopharma Inc12.26-239.47%
ADMAAdma Biologics Inc12.42-241.24%
HRMYHarmony Biosciences Holdings Inc13.82-257.19%
SABSSAB Biotherapeutics Inc14.14-260.78%
NAGENiagen Bioscience Inc14.82-268.54%
INCYIncyte Corp15.82-279.96%
REGNRegeneron Pharmaceuticals Inc15.86-280.35%
PBYIPuma Biotechnology Inc17.32-296.95%
CPRXCatalyst Pharmaceuticals Inc17.44-298.35%
EXELExelixis Inc17.54-299.48%
TGTXTG Therapeutics Inc18.97-315.72%
MDXGMimedx Group Inc20.55-333.76%
XOMAXOMA Royalty Corp22.87-360.18%
ARGXArgen X SE24.30-376.37%
CTMXCytomX Therapeutics Inc24.82-382.32%
XOMAOXOMA Royalty Corp25.34-388.28%
HALOHalozyme Therapeutics Inc25.62-391.45%
XOMAPXOMA Royalty Corp25.67-391.98%
VRTXVertex Pharmaceuticals Inc27.99-418.42%
RPRXRoyalty Pharma plc - Class A28.69-426.30%
SLNOSoleno Therapeutics Inc29.02-430.03%
ASNDAscendis Pharma A/S30.09-442.20%
LGNDLigand Pharmaceuticals Inc - Class B37.91-531.22%
APLSApellis Pharmaceuticals Inc39.02-543.84%
BMRNBiomarin Pharmaceutical Inc42.21-580.13%
ONCBeiGene Ltd69.54-890.97%
PHARPharming Group N.V.75.03-953.36%
TECHBio-Techne Corp101.96-1259.70%
VCELVericel Corp109.92-1350.27%
ALNYAlnylam Pharmaceuticals Inc117.96-1441.76%
GMABGenmab140.29-1695.70%
TLXTelix Pharmaceuticals Ltd162.15-1944.36%
CORTCorcept Therapeutics Inc212.86-2521.09%